作者: Peter Hawker , Rakesh Sinha
DOI: 10.1007/978-3-319-01913-0_12
关键词: Infliximab 、 Intensive care medicine 、 Internal medicine 、 Mercaptopurine 、 Management of Crohn's disease 、 Crohn's disease 、 Medicine 、 Life expectancy 、 Disease 、 Subspecialty 、 Incidence (epidemiology) 、 Gastroenterology
摘要: Crohn’s disease is a chronic relapsing inflammatory with both intestinal and extraintestinal manifestations that mainly affects young people, peak incidence in the early twenties. As does not affect life expectancy there as yet no cure, management long term undertaking. can present develop wide range of ways complex now considered subspecialty its own.